Crystal‑Form Innovation Underpins the Naturalization Folate Industry—The 2026 International Industry‑University‑Research‑Application Cooperation Conference (Jiangxi) Accelerates Active Folate Industrialization

Collaborative advancement for population‑wide health represents the strategic theme of the Healthy China Initiative.

Chapter 5, Section 1 of the *Healthy China 2030 Blueprint* advocates sound dietary practices, mandates the National Nutrition Program, disseminates dietary‑nutrition knowledge, and fosters evidence‑based eating habits among residents.

Folate is an essential nutrient for human health across the entire life cycle.

Folate was long associated primarily with prenatal supplementation. Today it finds expanding applications in staple‑food fortification and clinical nutrition.

Hosted by Nanchang University, the 2026 International Industry‑University‑Research‑Application Cooperation Conference (Jiangxi) convened in Nanchang on 25 October. Its dedicated International Symposium on Active Folate and Precision Nutrition & Health reviewed advances in basic and clinical research on active folate, alongside applied studies and R&D of novel raw materials, processes and technologies.

Industrial roll‑out targets three major market segments: complementary‑food nutrients, fortified wheat flour for staple‑food use, and modified milk powder. Three strategic‑cooperation signing ceremonies took place during the event, covering raw‑material supply, staple‑food fortification, and foods for special medical purposes (FSMP).

Tracing Origins: How Process Innovation Reshaped Folate Development

Folate, also known as vitamin B9, fuels cellular growth, division and proliferation in humans. Since the human body cannot synthesize folate endogenously, intake must come from foods or dietary supplements.

Dr. Zenglin Lian, Chief Scientist of Jinkang Hexin Pharmaceutical, reported that food‑derived natural folate was first discovered in 1931. Folate products later evolved into synthetic folic acid and early‑generation active folate. In 2012, the research team led by Yongzhi Cheng overcame technical hurdles to produce stable C‑crystal‑form 6S‑5‑methyltetrahydrofolate calcium.

C‑crystal naturalization folate delivers superior performance in stability, dissolution rate and particle‑size distribution, translating to improved dissolution and absorption efficiency.

Active folate and synthetic folic acid follow distinct metabolic pathways in‑vivo. Professor Zhesheng Chen from St. John’s University (USA) explained that synthetic folic acid undergoes two reduction steps catalyzed by dihydrofolate reductase, followed by methylation mediated by methylenetetrahydrofolate reductase (MTHFR). Three enzymatic reactions are required before synthetic folic acid becomes biologically available.

Active folate bypasses these transformations and enters human metabolic cycles directly.

Human dihydrofolate reductase has a finite metabolic capacity for synthetic folic acid, with substantial inter‑individual variability. Oral doses above roughly 200 μg of synthetic folic acid may lead to detectable unmetabolized folic acid in plasma.

Regulatory frameworks have progressively matured. In 2012, the former Ministry of Health issued GB 14880‑2012 *National Food Safety Standard — Standard for Use of Nutrient Fortifiers in Foods*. This standard permitted folate fortification in 11 food categories including modified milk and stipulated corresponding dosage limits; wheat flour may be fortified at 1 000‑3 000 μg/kg.

Announcement No. 13 of 2017 from the National Health Commission approved 6S‑5‑methyltetrahydrofolate calcium (active folate) as a new food‑nutrient fortifier. Announcements No. 6 (2020) and No. 2 (2021) successively broadened its permitted use scope. Announcement No. 7 (2025) extended approval to wheat flour, and Announcement No. 5 (2026) added complementary‑food nutrients to the permitted‑use list.

The group standard T/BPSPA 0016‑2022 *Naturalization Folate — 6S‑5‑Methyltetrahydrofolate Calcium* was published in 2022, establishing unified specifications covering manufacturing processes, raw‑material criteria, test protocols, labelling, packaging, transportation and storage.

Collaboration: Resolving Practical Challenges Along the Industrial Chain

Conference discussions repeatedly highlighted industry‑university‑research collaboration and real‑world product deployment, with particular focus on nutrition for older adults and patients with chronic diseases.

Associate Professor Zhaofeng Zhang, Deputy Director of the Department of Nutrition and Food Hygiene at Peking University School of Public Health, presented survey data showing Chinese older adults consume approximately 255 g of vegetables daily — well below the 500‑g recommended intake. Average daily fruit intake stands at merely 30.8 g, far short of the 200‑350 g dietary guideline.

Reported agricultural‑commodity consumption statistics do not equate to actual human ingestion. High‑heat stir‑frying, a staple of Chinese cuisine, degrades native food folate. Reliance solely on regular diets frequently leaves older adults with insufficient folate intake.

Addressing metabolic constraints among people carrying MTHFR gene polymorphisms, Professor Zhang outlined three key strengths of active folate: it operates independent of the MTHFR pathway, is minimally impacted by gene variants, and generates no unmetabolized folic acid.

Compared with synthetic folic acid, active folate is less likely to mask vitamin B12 deficiency and does not interfere with dihydrofolate reductase activity. It rapidly elevates red‑blood‑cell folate concentrations, crosses the blood‑brain barrier, and participates in homocysteine remethylation.

Multiple experts cited evidence from the China Stroke Primary Prevention Trial (CSPPT). As introduced by Junsheng Huo, this trial launched in 2012 and confirmed folate‑based intervention delivers substantial value for primary prevention of cardiovascular‑cerebrovascular diseases.

At the other end of the lifespan spectrum lies pediatric nutrition. Bin Cao recalled decades‑past public‑health challenges: stunting and malnutrition were prevalent among children in impoverished regions, where many seven‑to‑eight‑year‑olds exhibited physical development typical of five‑to‑six‑year‑olds.

In 2012 the National Health Commission rolled out the Nutrition Improvement Program for Children in Poor Areas, supplying daily nutrient sachets to infants aged 6‑24 months living in contiguous disadvantaged zones. Cao Bin recommended further formula optimization for these sachets to better support comprehensive childhood development. She summarized delivery frameworks as “two core mechanisms, three priority domains and six implementation measures”, stressing that evidence‑based nutrition should be embedded throughout infant‑care practices.

During the same thematic forum, Professor Chun‑Ying Kim from Yeungnam University (Republic of Korea) explored another topic: molecular mechanisms and functional validation of natural bioactive compounds for sarcopenia prevention and management.

“Many assume weakness and weight loss in advanced age are normal ageing phenomena, yet these may signal sarcopenia,” Professor Kim noted. After age 50, human skeletal‑muscle mass declines by an average of 1‑2 % annually, with accelerated loss after age 70. Evidence‑based physical exercise plus adequate nutrition represent primary sarcopenia‑management strategies. Nevertheless, sustained resistance training proves difficult for many older adults, and plain protein supplementation yields limited muscle‑synthesis benefits. Developing functional foods tailored for senior populations has become a key direction for sarcopenia intervention.

Foods for Special Medical Purposes (FSMP) represented another heavily‑discussed topic. Zegen Jiang, General Manager of Times FSMP Foods (Shenzhen) Co., Ltd., reported persistent technical bottlenecks in functional oral‑liquid R&D and manufacturing. Oral liquids undergo high‑temperature sterilization at 120 °C, which readily degrades active folate. Retention of active ingredients across the 24‑month shelf‑life constitutes another major industrial challenge.

Xiaodan Wu, Director of Product Quality at Jinkang Hexin Pharmaceutical, proposed mitigation strategies via process adjustment and staged ingredient addition: introduce active folate in low‑temperature downstream processing to avoid exposure to front‑end high‑heat sterilization, and deploy encapsulation technology to mitigate degradation triggered by heat, oxygen and humidity. Joint university‑enterprise trials should further balance sterilization compliance, nutrient retention and shelf‑life stability.

Degradation losses occurring as active folate transitions from laboratory to consumer tables were central to the industry salon discussions. Professor Liqiang Zou from Nanchang University College of Food Science explained that active folate readily degrades upon exposure to light, heat and oxygen. Even formulations dosed with sufficient active folate may deliver reduced bioavailable doses to end‑users. His research team evaluated multiple encapsulation approaches: protein‑polysaccharide microencapsulation, complex coacervation with secondary coating, hydrogels, inorganic carriers and modified nanoliposomes, ultimately selecting liposomes as the preferred delivery vehicle.

Professor Jun Chen (Nanchang University College of Food Science) addressed future staple‑food fortification applications. Encapsulation technology, he emphasized, is critical for folate fortification of staple foods. Once regularized industry‑university‑research partnerships are established, dosing protocols, standardized manufacturing workflows and analytical testing standards must keep pace to enable large‑scale deployment of active‑folate staple‑food fortification.

The three on‑site strategic‑cooperation signing ceremonies advanced industrial collaboration further. The Nanchang University International Food Innovation Research Institute settled into the Xiaolan Economic‑and‑Technological Development Zone of Nanchang. The institute hosts four technical platforms: high‑throughput strain screening, multi‑omics testing, fermentation engineering and flexible food pilot‑scale manufacturing. More than a dozen combinable pilot‑production lines with formal food‑manufacturing licensing enable direct market launch of pilot‑batch products. The institute has completed dozens of horizontal collaborative projects with zone‑based enterprises and co‑founded the Nanchang University‑Jinkang Hexin Nutrition and Health Research Institute together with Jinkang Hexin Pharmaceutical.

Chunbao Lai, Chairman of Lianyungang Jinkang Hexin Pharmaceutical, offered candid commentary on price‑quality dynamics: *“Your price floor defines your quality floor.”* Uncontrolled price‑driven competition erodes corporate R&D investment, gradually fostering an industry culture prioritizing marketing over technical innovation and quality assurance. Consumers ultimately suffer harm, alongside eroded sector‑wide reputation. Enterprises should collectively uphold reasonable market pricing so downstream brands maintain healthy profit margins necessary for sustained product innovation.

Commercial Realization: Turning Crystal‑Form Attributes Into Verifiable Product Metrics

As the originator enterprise behind naturalized folate, Jinkang Hexin Pharmaceutical pursues industry‑university‑research partnerships built around C‑crystal Magnafolate®. Joint work with universities and research institutes addresses concrete technical challenges through corporate‑affiliated research platforms.

Internal‑control purity for C‑crystal Magnafolate® reaches 99.8 %‑99.9 %, exceeding the 99.5 % benchmark specified in the 2017 Announcement No. 13. The related technology portfolio includes 62 authorized domestic and international invention patents and has driven five major rounds of active‑folate application upgrades across China. Jinkang Hexin also participated in drafting group standard T/BPSPA 0016‑2022 *Naturalization Folate — 6S‑5‑Methyltetrahydrofolate Calcium*. The company states it will continue to promote formulation of corresponding national food‑safety standards.

Active folate will enter ordinary diets via staple‑food carriers such as wheat flour, making nutritional intervention a routine lifestyle option. Conference‑attending experts affirmed that multi‑stakeholder cooperation will continue to strengthen the active‑folate industrial foundation via crystal‑form innovation, bringing safer, more stable naturalized‑folate products to households.